Deepika Jalota - 15 Sep 2023 Form 4 Insider Report for PMV Pharmaceuticals, Inc. (PMVP)

Role
Chief Development Officer
Signature
/s/ Winston Kung, by power of attorney
Issuer symbol
PMVP
Transactions as of
15 Sep 2023
Net transactions value
-$27,168
Form type
4
Filing time
18 Sep 2023, 16:26:37 UTC
Previous filing
15 May 2023
Next filing
22 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PMVP Common Stock Sale $27,168 -4,104 -12% $6.62 29,946 15 Sep 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported shares were sold to cover the reporting person's tax obligations in connection with the vesting of restricted stock units, or RSUs.